John J. McCabe, Chief Financial Officer at Eleven Biotherapeutics, Inc. (EBIO), sold 1,399 shares at $2.10 ($3K) on 2017-02-14, disclosed to the SEC on 2017-02-16.
Open-market sale of $3k EBIO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |